CVRx (NASDAQ: CVRX) officer receives major equity grants, sells shares to cover taxes

Rhea-AI Filing Summary

CVRx, Inc. Chief Marketing & Strategy Officer Paul Verrastro reported a mix of equity grants and a small sale. On February 27, 2026, he acquired 45,000 shares of common stock as restricted stock units and a 67,000-share stock option grant, both at no cost.

The restricted stock units vest 25% on each annual anniversary of the grant date, while the option vests 25% on February 27, 2027 and then monthly in equal installments. On March 2, 2026, he sold 1,284 shares of common stock at a weighted average price of $7.9021 per share, in transactions ranging from $7.90 to $7.98, to satisfy tax withholding obligations through a mandated sell-to-cover transaction. Following the sale, he directly held 60,551 shares of common stock and 67,000 stock options.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VERRASTRO PAUL

(Last) (First) (Middle)

9201 W BROADWAY AVE

#650

(Street)

MINNEAPOLIS MN 55445

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF MKTG & STRAT OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		45,000(1)	A	$0	61,835	D
Common Stock	03/02/2026		S(2)		1,284	D	$7.9021(3)	60,551	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.16	02/27/2026		A		67,000		(4)	02/26/2036	Common Stock	67,000	$0	67,000	D

Explanation of Responses:

1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

2. The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

3. Reflects the weighted average price of 1,284 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

4. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

	/s/ Amy C. Seidel, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CVRX officer Paul Verrastro report in this Form 4 filing?

Paul Verrastro reported new equity awards and a small sale. He received 45,000 restricted stock units, a 67,000-share stock option grant, and sold 1,284 common shares to cover tax withholding obligations under the issuer’s award agreement.

How many CVRX restricted stock units did Paul Verrastro receive?

He received 45,000 restricted stock units of CVRx common stock. These units vest as to 25% of the shares on each annual anniversary of the grant date, creating a four-year vesting schedule tied to continued service with the company.

What are the terms of Paul Verrastro’s new CVRX stock option grant?

He was granted a stock option for 67,000 CVRx shares at an exercise price of $0.00. The option vests 25% on February 27, 2027, and then 1/48th of the shares each month thereafter, providing gradual monthly vesting following the initial cliff.

Why did Paul Verrastro sell 1,284 shares of CVRX common stock?

The 1,284-share sale was mandated by CVRx’s award agreement to satisfy tax withholding obligations. It was executed as a sell-to-cover transaction, meaning shares were sold automatically to cover taxes due upon the equity award vesting or grant.

At what prices were Paul Verrastro’s CVRX shares sold on March 2, 2026?

The 1,284 CVRx shares were sold at a weighted average price of $7.9021 per share. Individual sale prices ranged from $7.90 to $7.98, across multiple transactions executed on March 2, 2026, as disclosed in the Form 4 footnote.

How many CVRX shares does Paul Verrastro hold after these transactions?

After the reported transactions, Paul Verrastro directly held 60,551 shares of CVRx common stock. He also held a stock option covering 67,000 shares, reflecting his updated post-transaction ownership position as reported in the Form 4 filing.